Patents by Inventor Jacqueline Benson

Jacqueline Benson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-23p40 Specific Immunoglobulin Derived Proteins, Compositions, Epitopes, Methods and Uses
    Publication number: 20080038831
    Abstract: An anti-IL-23 specific human Ig derived protein, isolated nucleic acids that encode at least one anti-IL-23 Ig derived protein, vectors, host cells, transgenic animals or plants, and methods of making and using thereof are useful as therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably binds to one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.
    Type: Application
    Filed: June 26, 2007
    Publication date: February 14, 2008
    Inventors: Jacqueline Benson, Mark Cunningham, Jeffrey Luo
  • HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES
    Publication number: 20070218064
    Abstract: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Application
    Filed: December 28, 2006
    Publication date: September 20, 2007
    Inventors: Jacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya Orlovsky, Robert Rauchenberger, Raymond Sweet
  • IL-23p40 specific immunoglobulin derived proteins
    Patent number: 7252971
    Abstract: An anti-IL-23 specific human Ig derived protein is useful in therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably includes one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: August 7, 2007
    Assignee: Centocor, Inc.
    Inventors: Jacqueline Benson, Mark Cunningham, Jeffrey Luo
  • IL-23p40 specific antibody
    Patent number: 7247711
    Abstract: Novel anti-IL-23p40 specific human Ig derived proteins, including, without limitation, antibodies, fusion proteins, and mimetibodies, isolated nucleic acids that encode the anti-IL-23p40 Ig derived proteins, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, are useful for therapeutic compositions, methods and devices. Preferably, the anti-IL-23p40 specific human Ig derived proteins do not bind the p40 subunit of IL-12 and, thus, do not neutralize IL-12-related activity.
    Type: Grant
    Filed: May 6, 2004
    Date of Patent: July 24, 2007
    Assignee: Centocor, Inc.
    Inventors: Jacqueline Benson, Mark Cunningham
  • Anti-IL-23 antibodies, compositions, methods and uses
    Publication number: 20070009526
    Abstract: An anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Application
    Filed: June 30, 2006
    Publication date: January 11, 2007
    Inventors: Jacqueline Benson, Mark Cunningham, Cynthia Duchala, Jill Giles-Komar, Jinquan Luo, Michael Rycyzyn, Sweet Raymond
  • Anti-amyloid antibodies, compositions, methods and uses
    Publication number: 20060246075
    Abstract: The present invention relates to at least one novel anti-amyloid antibody, including isolated nucleic acids that encode at least one anti-amyloid antibody, amyloid, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: September 28, 2005
    Publication date: November 2, 2006
    Inventors: Marc Mercken, Jacqueline Benson
  • IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses
    Publication number: 20060067936
    Abstract: An anti-IL-23 specific human Ig derived protein, isolated nucleic acids that encode at least one anti-IL-23 Ig derived protein, vectors, host cells, transgenic animals or plants, and methods of making and using thereof are useful as therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably binds to one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.
    Type: Application
    Filed: September 23, 2005
    Publication date: March 30, 2006
    Inventors: Jacqueline Benson, Mark Cunningham, Jeffrey Luo
  • IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
    Publication number: 20050137385
    Abstract: Novel anti-IL-23p40 specific human Ig derived proteins, including, without limitation, antibodies, fusion proteins, and mimetibodies, isolated nucleic acids that encode the anti-IL-23p40 Ig derived proteins, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, are useful for therapeutic compositions, methods and devices. Preferably, the anti-IL-23p40 specific human Ig derived proteins do not bind the p40 subunit of IL-12 and, thus, do not neutralize IL-12-related activity.
    Type: Application
    Filed: May 6, 2004
    Publication date: June 23, 2005
    Inventors: Jacqueline Benson, Mark Cunningham
  • Anti-amyloid antibodies, compositions, methods and uses
    Publication number: 20050129695
    Abstract: The present invention relates to at least one novel anti-amyloid antibody, including isolated nucleic acids that encode at least one anti-amyloid antibody, amyloid, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: March 26, 2004
    Publication date: June 16, 2005
    Inventors: Marc Mercken, Jacqueline Benson